Aquatic Capital Management LLC Sells 9,308 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

Aquatic Capital Management LLC cut its holdings in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 74.5% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 3,192 shares of the technology company's stock after selling 9,308 shares during the period. Aquatic Capital Management LLC's holdings in Simulations Plus were worth $89,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Jones Financial Companies Lllp boosted its position in Simulations Plus by 53.6% during the 4th quarter. Jones Financial Companies Lllp now owns 1,223 shares of the technology company's stock worth $34,000 after purchasing an additional 427 shares during the period. Johnson Financial Group Inc. acquired a new stake in shares of Simulations Plus in the fourth quarter valued at approximately $39,000. Tower Research Capital LLC TRC boosted its holdings in shares of Simulations Plus by 42.2% in the fourth quarter. Tower Research Capital LLC TRC now owns 2,575 shares of the technology company's stock valued at $72,000 after acquiring an additional 764 shares in the last quarter. AlphaQuest LLC boosted its holdings in shares of Simulations Plus by 502.9% in the fourth quarter. AlphaQuest LLC now owns 2,689 shares of the technology company's stock valued at $75,000 after acquiring an additional 2,243 shares in the last quarter. Finally, KLP Kapitalforvaltning AS bought a new stake in Simulations Plus during the fourth quarter worth approximately $86,000. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, Director Walter S. Woltosz sold 20,000 shares of the firm's stock in a transaction on Thursday, May 1st. The shares were sold at an average price of $33.51, for a total transaction of $670,200.00. Following the sale, the director now directly owns 3,344,157 shares in the company, valued at $112,062,701.07. This trade represents a 0.59% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 19.40% of the company's stock.

Simulations Plus Stock Down 0.8%

NASDAQ:SLP traded down $0.23 on Friday, reaching $30.02. The stock had a trading volume of 150,697 shares, compared to its average volume of 208,874. The company has a market capitalization of $603.73 million, a P/E ratio of 75.05 and a beta of 1.10. Simulations Plus, Inc. has a 1-year low of $23.01 and a 1-year high of $51.22. The stock has a fifty day moving average price of $28.76 and a 200-day moving average price of $30.23.

Simulations Plus (NASDAQ:SLP - Get Free Report) last released its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.25 by $0.06. Simulations Plus had a net margin of 10.97% and a return on equity of 6.84%. The business had revenue of $22.43 million for the quarter, compared to analysts' expectations of $21.93 million. During the same period in the prior year, the firm earned $0.20 earnings per share. Simulations Plus's revenue was up 22.5% compared to the same quarter last year. Sell-side analysts predict that Simulations Plus, Inc. will post 1.09 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research firms recently commented on SLP. KeyCorp raised their price objective on shares of Simulations Plus from $32.00 to $40.00 and gave the stock an "overweight" rating in a research note on Wednesday, April 16th. StockNews.com upgraded shares of Simulations Plus from a "sell" rating to a "hold" rating in a report on Monday, April 28th. Two equities research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $50.00.

About Simulations Plus

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.